We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.75B
Cap. Flow %
-19.89%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.76%
3 Healthcare 14.3%
4 Real Estate 8.12%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZWRK
426
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
$2.81M 0.03%
285,150
-28,667
-9% -$282K
SPCM
427
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$2.81M 0.03%
275,741
-27,604
-9% -$279K
BZAI
428
Blaize Holdings
BZAI
$138M
$2.81M 0.03%
280,744
-28,105
-9% -$280K
HMA
429
DELISTED
Heartland Media Acquisition Corp.
HMA
$2.81M 0.03%
280,744
-28,105
-9% -$280K
TGR
430
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
$2.8M 0.03%
275,741
-27,604
-9% -$278K
SO icon
431
Southern Company
SO
$107B
$2.79M 0.03%
+41,059
New +$3.11M
CC icon
432
Chemours
CC
$2.27B
$2.76M 0.03%
112,121
-81,373
-42% -$2.68M
ROIC
433
DELISTED
Retail Opportunity Investments Corp.
ROIC
$2.76M 0.03%
200,612
-107,016
-35% -$1.77M
UTHR icon
434
United Therapeutics
UTHR
$22.9B
$2.76M 0.03%
13,162
+4,900
+59% +$1.1M
RVNC
435
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.73M 0.03%
101,179
-74,000
-42% -$1.5M
BCRX icon
436
BioCryst Pharmaceuticals
BCRX
$2.38B
$2.73M 0.03%
216,327
-20,000
-8% -$257K
SDST
437
Stardust Power Inc
SDST
$6.68M
$2.73M 0.03%
27,368
-2,867
-9% -$284K
DOCS icon
438
Doximity
DOCS
$3.77B
$2.72M 0.03%
90,000
-10,000
-10% -$366K
BSX icon
439
Boston Scientific
BSX
$71.4B
$2.71M 0.03%
70,005
-63,000
-47% -$2.53M
SLAM
440
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.71M 0.03%
273,608
-250,216
-48% -$2.47M
SANB
441
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
$2.71M 0.03%
267,649
GLHA
442
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$2.71M 0.03%
275,741
-27,604
-9% -$271K
TWTR
443
PUT
DELISTED
Twitter, Inc.
TWTR
$2.71M 0.03%
455,100
+900
+0.2% +$36.6K
SCOB
444
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$2.71M 0.03%
272,086
-27,339
-9% -$270K
AXGN icon
445
Axogen
AXGN
$2.38B
$2.69M 0.03%
225,477
+40,000
+22% +$400K
ADER
446
DELISTED
26 Capital Acquisition Corp
ADER
$2.69M 0.03%
272,208
-27,250
-9% -$269K
HIW icon
447
Highwoods Properties
HIW
$3.47B
$2.69M 0.03%
+99,622
New +$3.22M
PSAG
448
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
$2.68M 0.03%
272,840
-27,314
-9% -$268K
PHYT
449
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$2.67M 0.03%
262,511
VSAC
450
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.66M 0.03%
262,486
-26,277
-9% -$265K

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.75B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.